Ghost Tree Capital, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Ghost Tree Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $1.1 Million - $2.29 Million	-40,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $12.7 Million - $17.9 Million	-310,000 Reduced 88.57%	40,000 $2.18 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $9.35 Million - $12.4 Million	250,000 Added 250.0%	350,000 $14.6 Million
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $6.96 Million - $11.7 Million	-175,000 Reduced 63.64%	100,000 $4.38 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $2.23 Million - $3.22 Million	75,000 Added 37.5%	275,000 $10.2 Million
Q3 2018 Nov 14, 2018	SELL	$32.79 - $43.0 $11.5 Million - $15.1 Million	-350,000 Reduced 63.64%	200,000 $7.51 Million
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $8.21 Million - $12.6 Million	365,000 Added 197.3%	550,000 $14.2 Million
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $3.78 Million - $6.58 Million	185,000	185,000 $4.99 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.